Santhera Pharmaceuticals Holding Ltd. header image

Santhera Pharmaceuticals Holding Ltd.

SANN

Equity

ISIN CH1276028821 / Valor 127602882

SIX Swiss Exchange (2026-07-02)

CHF 15.20-0.26%

Santhera Pharmaceuticals Holding Ltd.
UMushroom community rating:

5.00 1 votes No rating yet

NegativeNeutralPositive

About company

Santhera Pharmaceuticals Holding Ltd. is a Swiss specialty pharmaceutical company that develops and commercializes therapies for rare neuromuscular, mitochondrial and related pulmonary disorders. Its work has centered on orphan-drug programs — most prominently formulations of idebenone (marketed in some indications) — and clinical development efforts in Duchenne muscular dystrophy and other rare disease indications. The company operates as a typical small-cap biotech, generating revenues from product sales where marketed and from partnerships, milestone and licensing arrangements, while relying on ongoing clinical development, regulatory filings and capital markets financing to advance its pipeline and expand geographic reach.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

29.7%1Y

84.2%3Y

-41.8%5Y

Performance

52.7%1Y

54.8%3Y

66.4%5Y

Volatility

253 M

Market cap (USD)

46,615

Daily traded volume (Shares)

12.7 / 11.56

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

5.00

1 votes

Performance:

5.00

Innovation:

5.00

Society:

5.00

Nature:

5.00

Luba Schoenig

Switzerland, 20 Mar 2025

Ein top innovatives Unternehmen, das sich auf die Behandlung von DMD spezialisiert und seine Marktstellung kontinuierlich ausbaut

EQUITIES OF THE SAME SECTOR

NXP Semiconductors N.V.

NXP Semiconductors N.V. Valor: 11569795

Annual Return

-50%0%+50%

Risk level

110

-2.08%USD 273.36

Tata Technologies Limited

Tata Technologies Limited Valor: 130929623

Annual Return

-50%0%+50%

Risk level

110

6.24%INR 712.30

CPU Softwarehouse AG

CPU Softwarehouse AG Valor: 4924656

Annual Return

-50%0%+50%

Risk level

110

20.67%EUR 0.36

TeamViewer SE

TeamViewer SE Valor: 50049146

Annual Return

-50%0%+50%

Risk level

110

0.00%EUR 5.24

Basler AG

Basler AG Valor: 207929

Annual Return

-50%0%+50%

Risk level

110

-3.04%EUR 27.10

CeoTronics Aktiengesellschaft Audio . Video . Data Communication

CeoTronics Aktiengesellschaft Audio . Video . Data Communication Valor: 942127

Annual Return

-50%0%+50%

Risk level

110

0.54%EUR 9.25

CANCOM SE

CANCOM SE Valor: 883557

Annual Return

-50%0%+50%

Risk level

110

3.14%EUR 24.65

plenum AG

plenum AG Valor: 29187745

Annual Return

-50%0%+50%

Risk level

110

2.07%EUR 2.96

Vicor Corp

Vicor Corp Valor: 983399

Annual Return

-50%0%+50%

Risk level

110

-19.21%USD 282.95

Microsoft Corp

Microsoft Corp Valor: 951692

Annual Return

-50%0%+50%

Risk level

110

1.62%USD 389.88

SIX

FactSet

Clearbit

Logos provided by Clearbit